Zim Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹105 crore and a net loss of ₹2.05 crore for the September 2026 quarter.
Zim Laboratories (NSE: ZIMLAB) closed at ₹147.80 on 20 Nov 2026. Its market capitalisation is ₹793 crore and it trades at 383.1 times earnings.
Incorporated in 1989, Zim Laboratories Ltd manufactures formulation drugs and pre formulation ingredients in India and markets and sells these within and out side India
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.